On September 29, 2022, Representatives Miller-Meeks, O’Halleran, and Murphy introduced legislation requiring the Foodand Drug Administration (FDA) to conduct a study and issue recommendations on improving medical device data interoperability.
Morgan Reed, executive director of the Connected Health Initiative (CHI), expressed CHI’s support for the bill:
“Interoperability is critical to realize the promise of digital health and enable better, more cost-effective, patient-centered care. Patients and caregivers benefit immensely from the introduction of new, innovative medical devices and their evolving data collection and analysis capabilities, and interoperability helps maximize these benefits,” said Morgan. “The success of value-based care models will increasingly rely on digital health tools that synthesize a patient’s or a population’s health information to produce an accurate and actionable diagnosis. We applaud this legislation as an important, incremental step toward better data interoperability across the wide range of medical devices in use today and in the future.”
